PROTECTIVE EFFECT OF PROPRANOLOL IN THREATENED MYOCARDIAL INFARCTION
- 28 October 1978
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 312 (8096), 907-909
- https://doi.org/10.1016/s0140-6736(78)91628-8
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Reduction of enzyme levels by propranolol after acute myocardial infarction.Circulation, 1978
- PLASMA PROPRANOLOL CONCENTRATION IN PATIENTS WITH ANGINA AND ACUTE MYOCARDIAL INFARCTIONClinical and Experimental Pharmacology and Physiology, 1976
- Clinical measurement of myocardial infarct size. Modification of a method for the estimation of total creatine phosphokinase release after myocardial infarction.Circulation, 1975
- A simple and rapid fluorometric method for the estimation of 1-(2-hydroxy-3-isopropylamino-propoxy)-naphthalene hydrochloride, propranolol, in bloodClinica Chimica Acta; International Journal of Clinical Chemistry, 1974
- Estimation of Infarct Size in Man and its Relation to PrognosisCirculation, 1972
- Factors Influencing Infarct Size Following Experimental Coronary Artery OcclusionsCirculation, 1971
- Trial of propranolol in acute myocardial infarction.BMJ, 1968
- ABSENCE OF PROPHYLACTIC EFFECT OF PROPRANOLOL IN MYOCARDIAL INFARCTIONThe Lancet, 1966
- A CONTROLLED TRIAL OF PROPRANOLOL IN ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1966
- EFFECT OF PROPRANOLOL IN MYOCARDIAL INFARCTIONThe Lancet, 1965